Skip to main content
padlock icon - secure page this page is secure

Management of intermediate‐risk pulmonary embolism: uncertainties and challenges

Buy Article:

$59.00 + tax (Refund Policy)

Current guidelines on the treatment of acute pulmonary embolism (PE) recommend stratification of hemodynamically stable patients in ‘low risk’ and ‘intermediate risk’. Validated risk scores, cardiac biomarkers, and imaging of the right ventricle all help in distinguishing both patient categories. The relevance of this risk stratification lies in the determination of the most optimal treatment for the individual patient. In this clinical review, we will discuss how patients with ‘intermediate‐risk’ PE can be identified as well as recent advances in their therapeutic management. Based on a clinical case, we will highlight the indications for reperfusion therapy and the current experience with non‐vitamin K‐dependent oral anticoagulant (NOACs) in this specific patient's category.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: fibrinolysis; intermediate risk; outpatient treatment; pulmonary embolism; treatment

Document Type: Research Article

Publication date: December 1, 2015

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more